Capital expenditure increased 341.9%
Capital expenditure changed +341.9% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +341.9% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Cash & equivalents changed -36.1% from the comparable as-filed period.
Debt changed -98.9% from the comparable as-filed period.
Gross margin changed -498 basis points from the comparable as-filed period.
Inventory changed +24.2% from the comparable as-filed period.
Net income changed -38.5% from the comparable as-filed period.
Operating income changed -26.8% from the comparable as-filed period.
Operating margin changed -899 basis points from the comparable as-filed period.
Capex / revenue changed +106 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -14.2% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Revenue changed +6.5% from the comparable as-filed period.
Operating cash flow changed -10.4% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Stock-based compensation changed +8.5% from the comparable as-filed period.
Gross profit changed -3.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.